Summary
One hundred seventy-five clinical isolates ofHaemophilus influenzae (including 74 β-lactamaseproducing strains) were examined for susceptibility to ampicillin, cefonicid, cefamandole, cefuroxime and cefotaxime. Cefonicid and cefamandole exhibited similar activity against ampicillin-susceptible strains (MIC90 = 0.2 mg/l for both antibiotics); cefuroxime was slightly less active (MIC90 = 0.01 mg/l). However, cefonicid, cefuroxime and cefotaxime were all more active against β-lactamase-producingH. influenzae than cefamandole (MIC90 = 1.0 mg/l for cefonicid, MIC90 = 2.0 mg/l for cefuroxime, MIC90 = 0.01 mg/l for cefotaxime, MIC90 = 5.0 mg/l for cefamandole). One hundred twenty-five of the 175 isolates were also tested for susceptibility to cefonicid and cefamandole by disc diffusion technique and a plot of zone diameter vs. MIC was analyzed for the β-lactamase-producing strains.
Zusammenfassung
175 klinische Isolate vonHaemophilus influenzae (einschließlich 74 β-Laktamase bildenden Stämmen) wurden auf ihre Empfindlichkeit gegen Ampicillin, Cefonicid, Cefamandol, Cefuroxim und Cefotaxim untersucht. Die Aktivität gegen Ampicillin-empfindliche Stämme war bei Cefonicid und Cefamandol ähnlich (MHK für beide Antibiotika 0,2 mg/l); Cefuroxim zeigte etwas geringere Aktivität (MHK 1,0 mg/l); die Wirksamkeit von Cefotaxim war signifikant stärker (MHK90 0,01 mg/l). Gegen β-Laktamase bildendeH. influenzae waren dagegen Cefonizid, Cefuroxim und Cefotaxim dem Cefamandol überlegen (MHK90-Werte für Cefonizid 1,0 mg/l; für Cefuroxim 2,0 mg/l; für Cefotaxim 0,01 mg/l und für Cefamandol 5,0 mg/l). Bei 125 der 175 Isolate wurde die Empfindlichkeit gegen Cefonizid und Cefamandol auch im Blättchendiffusionstest bestimmt und für die β-Laktamase-Bildner wurde die Kurve für die Hemmhofdurchmesser gegenüber den MHK-Werten analysiert.
Similar content being viewed by others
References
Doern, G. V., Jørgensen, J. H., Thornsberry, C., Preston, D. A., Tubert, T., Redding, J. S., Maher, L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates ofHaemophilus influenzae. Antimicrob. Agents Chemother. 32 (1988) 180–185.
Campos, J., Garcia-Tornel, S., Sanfeliu, I. Susceptibility studies of multiply resistantHaemophilus influenzae isolated from pediatric patients and contacts. Antimicrob. Agents Chemother. 25 (1984) 706–709.
Arpi, M., Honberg, P. Z., Frimodt-Møller, N. Antibiotic susceptibility ofHaemophilus influenzae isolated from cerebrospinal fluid and blood. Acta Path. Microbiol. Immunol. Scand. Sect. B 94 (1986) 167–171.
Berardi-Grassias, L. D., Boisivon, A., Bigel, M. L. A study of susceptibility to ampicillin of 148 strains ofHaemophilus influenzae isolated in two general hospitals. Path. Biol. 35 (1987) 523–525.
Wallace, R. J., Niefield, S. L., Waters, S., Waters, B., Awe, R. J., Wiss, K., Martin, R. R., Greenberg, S. B. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia. Antimicrob. Agents Chemother. 21 (1982) 231–235.
Geckler, R. W., McCormack, G. D., Goodman, J. S. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract. Rev. Infect. Dis. 6 (Suppl. 4) (1984) S 847-S 852.
Simelaro, J. P., Good, J. T., Lentnek, A. L. Multiclinic comparison of cefonicid and cefamandole in hospitalized patients with lower respiratory tract infections. Adv. Ther. 2 (1985) 192–202.
Meyers, B. R. Treating community-acquired lower respiratory infection. Am. Fam. Physician 28 (1983) 204–210.
Gold, B., Rodriquez, W. J. Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions and therapeutic indications. Pharmacotherapy 3 (1983) 82–99.
Shelton, S., Nelson, J. D., McCracken, G. H. In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13–9904, and other cephalosporins. Antimicrob. Agents Chemother. 18 (1980) 476–479.
Dabernat, H. J., Delmas, C. Comparative activity of cefotaxime and selected β-lactam antibiotics againstHaemophilus influenzae and aerobic gram-negative bacilli. Rev. Infect. Dis. 4 (1982) S 401-S 405.
Syriopoulou, V. Ph., Scheiffle, D. W., Sack, C. M., Smith, A. L. Effect of inoculum size on the susceptibility ofHaemophilus influenzae b to beta-lactam antibiotics. Antimicrob. Agents Chemother. 16 (1979) 510–513.
Steers, E., Foltz, E. L., Graves, B. S. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot. Chemother. 4 (1959) 307–311.
Kalin, M., Lindberg, A. A., Tunevall, G. Etiologic diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Scand. J. Infect. Dis. 15 (1983) 153–160.
Mendelman, P. M., Chaffin, D. O., Stull, T. L., Rubens, C. E., Mack, K. D., Smith, A. L. Characterization of non-β-lactamase-mediated ampicillin resistance inHaemophilus influenzae. Antimicrob. Agents Chemother. 26 (1984) 235–244.
Bauer, A. W., Kirby, W. M. M., Sherris, J. C., Turck, M. Antibiotic susceptibility testing by a standardized simple disc method. Am. J. Clin. Pathol. 45 (1966) 493–496.
National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests. Approved M2–A3. Philadelphia, PA: National Committee for Clinical Laboratory Standards (1985).
Cunha, B. Single-dose therapy with cefonicid: a review of its clinical and economic benefits. Adv. Ther. 2 (1985) 177–191.
Bergeron, M. G., Claveau, S., Simard, P. Limitedin vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producingHaemophilus influenzae strains: comparison of moxalactam, chloamphenicol and ampicillin. Antimicrob. Agents Chemother. 19 (1981) 101–105.
Kattan, S., Cavanagh, P., Williams, J. D. Relationship between β-lactam antibiotics againstHaemophilus influenzae. Antimicrob. Agents Chemother. 1 (1975) 79–84.
Jørgensen, J. H., Alexander, G. A. Comparative activities of selected beta-lactam antibiotics againstHaemophilus influenzae. Antimicrob. Agents Chemother. 13 (1978) 342–343.
Piot, P., Van Dyck, E., Colaert, J. In vitro activity of ceftazidime (GR20263) and other β-lactam antibiotics againstHaemophilus influenzae. Infection 11 Suppl. 1 (1983) S 32-S 34.
Thirumoorthi, M. C., Kobos, D. M., Dajani, A. S. Susceptibility ofHaemophilus influenzae to chloramphenicol and eight beta-lactam antibiotics. Antimicrob. Agents Chemother. 20 (1981) 208–213.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burns, J.L., Wong, K. & Smith, A.L. In vitro activity of second and third generation cephalosporins against ampicillin susceptible and resistant haemophilus influenzae. Infection 16, 293–296 (1988). https://doi.org/10.1007/BF01645075
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01645075